Maria Jumalon
Family · Henderson, NVNPI 1336618339
Payments from drug & device makers
Across 157 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$276
- Nestle Healthcare Nutrition Inc.$222
- Redhill Biopharma Inc.$211
- Sanofi$201
- Braintree Laboratories, Inc.$169
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,14796%
- Education$762%
- Gifts$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,181 |
| Johnson & Johnson | 17 | $276 |
| Nestle Healthcare Nutrition Inc. | 7 | $222 |
| Redhill Biopharma Inc. | 11 | $211 |
| Sanofi | 13 | $201 |
| Braintree Laboratories, Inc. | 10 | $169 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $154 |
| Lilly USA, LLC | 1 | $124 |
| AstraZeneca | 1 | $122 |
| Ironwood Pharmaceuticals, Inc | 7 | $121 |
| Gilead | 5 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $96 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Intercept Pharmaceuticals, Inc. | 3 | $54 |
| Ardelyx, Inc. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Biodelivery Sciences International, Inc. | 3 | $42 |
| Pfizer | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,283 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 113 | $96,226 |
| LinzessLinaclotide | 29 | $20,155 |
| OzempicSemaglutide | 15 | $16,260 |
| JardianceEmpagliflozin | 14 | $15,223 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,512 |
| MyrbetriqMirabegron | 15 | $7,852 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $2,884 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,588 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,364 |
| Omeprazole | 83 | $2,028 |
| Gabapentin | 107 | $1,862 |
| Hydroxyzine Hcl | 61 | $1,632 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $1,328 |
| Atorvastatin Calcium | 125 | $1,069 |
| Levothyroxine Sodium | 134 | $997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $19 | $96,226113 claims |
| AbbVieLinzess | $1,181 | $20,15529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,501 family providers in Nevada.
Other family in Henderson
- Kristy SolisHenderson$23K
- Joseph LauHenderson$18K
- Judith YuHenderson$14K
- Daniel Sam AciertoHenderson$11K
- Reiko TapiaHenderson$10K
- Francis TorresHenderson$8K
- John PhoenixLas Vegas$281K
- Hollie TylerLas Vegas$118K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.